Development status: Approved, off-patent

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Antiinflammatory action

Additional information: Synthetic sufanilamide derivative. Prodrug with active metabolites 5-aminosalicylic acid and sulfapyridine. Oral use as antiinflammatory drug for ulcerative colitis, Crohn's disease and rheumatoid arthritis.